Author details

Full Name

Nicole F Bernard

Affiliation

ORCID

Career Start Year

1979

Papers

132

H Index

Expertise

CM4AI Collaborator

PMID	Paper Title	Journal Title	Published Year
36851537	The Frequency and Function of NKG2CCD57 Adaptive NK Cells in Cytomagalovirus Co-Infected People Living with HIV Decline with Duration of Antiretroviral Therapy.		2023
34913882	Unbiased immune profiling reveals a natural killer cell-peripheral nerve axis in fibromyalgia.	Pain	2022
35766089	Contribution of Natural Killer cells to HIV control in Elite Controllers.	Virologie	2022
35746615	NK Cells in Protection from HIV Infection.	Viruses	2022
36267915	MiRNA-103 downmodulates CCR5 expression reducing human immunodeficiency virus type-1 entry and impacting latency establishment in CD4 TÂ cells.	iScience	2022
36197157	High frequencies of adaptive NK cells are associated with absence of coronary plaque in cytomegalovirus infected people living with HIV.	Medicine (United States)	2022
35720328	Natural Killer Cells in Antibody Independent and Antibody Dependent HIV Control.	Frontiers in Immunology	2022
35336860	Distinct Plasma Concentrations of Acyl-CoA-Binding Protein (ACBP) in HIV Progressors and Elite Controllers.	Viruses	2022
34586863	Evolution of Antibodies to Native Trimeric Envelope and Their Fc-Dependent Functions in Untreated and Treated Primary HIV Infection.	Journal of Virology	2021
34076484	Influence of NKG2C Genotypes on HIV Susceptibility and Viral Load Set Point.	Journal of Virology	2021
34122431	Loss of CD96 Expression as a Marker of HIV-Specific CD8 T-Cell Differentiation and Dysfunction.	Frontiers in Immunology	2021
33318292	Peculiar Phenotypic and Cytotoxic Features of Pulmonary Mucosal CD8 T Cells in People Living with HIV Receiving Long-Term Antiretroviral Therapy.	J Immunol	2021
32756974	Anti-cytomegalovirus Immunoglobulin G Is Linked to CD4 T-cell Count Decay in Human Immunodeficiency Virus (HIV) Elite Controllers.	Clinical Infectious Diseases	2021
31504638	Plasma Levels of C-Type Lectin REG3Î± and Gut Damage in People With Human Immunodeficiency Virus.	Journal of Infectious Diseases	2020
32268275	Persistent expansion and Th1-like skewing of HIV-specific circulating T follicular helper cells during antiretroviral therapy.	eBioMedicine	2020
33101312	Polyfunctional Fc Dependent Activity of Antibodies to Native Trimeric Envelope in HIV Elite Controllers.	Frontiers in Immunology	2020
31270222	HLA-F on Autologous HIV-Infected Cells Activates Primary NK Cells Expressing the Activating Killer Immunoglobulin-Like Receptor KIR3DS1.	Journal of Virology	2019
31848282	Antibody-Dependent Cellular Cytotoxicity-Competent Antibodies against HIV-1-Infected Cells in Plasma from HIV-Infected Subjects.	mBio	2019
31511383	The Education of NK Cells Determines Their Responsiveness to Autologous HIV-Infected CD4 T Cells.	Journal of Virology	2019
31141927	Quantifying Anti-HIV Envelope-Specific Antibodies in Plasma from HIV Infected Individuals.	Viruses	2019
30698860	Differential contribution of education through KIR2DL1, KIR2DL3, and KIR3DL1 to antibody-dependent (AD) NK cell activation and ADCC.	Journal of Leukocyte Biology	2019
30696399	Expression of ligands for activating natural killer cell receptors on cell lines commonly used to assess natural killer cell function.	BMC Immunology	2019
29280757	KIR3DL1 alleles and their epistatic interactions with human leukocyte antigen class I influence resistance and susceptibility to HIV-1 acquisition in the Pumwani sex worker cohort.	AIDS	2018
29222166	Effect of IL-7 Therapy on Phospho-Ribosomal Protein S6 and TRAF1 Expression in HIV-Specific CD8 T Cells in Patients Receiving Antiretroviral Therapy.	Journal of Immunology	2018
29136520	Characterization of myeloid cell populations in human testes collected after sex reassignment surgery.	J Reprod Immunol	2018
29743316	HLA-F on HLA-Null 721.221 Cells Activates Primary NK Cells Expressing the Activating Killer Ig-like Receptor KIR3DS1.	Journal of Immunology	2018
28084796	Beyond Viral Neutralization.	AIDS Research and Human Retroviruses	2017
28893287	Natural killer (NK) cell receptor-HLA ligand genotype combinations associated with protection from HIV infection: investigation of how protective genotypes influence anti HIV NK cell functions.	AIDS Research and Therapy	2017
28893184	The Canadian HIV and aging cohort study - determinants of increased risk of cardio-vascular diseases in HIV-infected individuals: rationale and study protocol.	BMC Infectious Diseases	2017
28938026	HIV exposed seronegative (HESN) compared to HIV infected individuals have higher frequencies of telomeric Killer Immunoglobulin-like Receptor (KIR) B motifs; Contribution of KIR B motif encoded genes to NK cell responsiveness.	PLoS ONE	2017
28883824	Natural Killer (NK) Cell Education Differentially Influences HIV Antibody-Dependent NK Cell Activation and Antibody-Dependent Cellular Cytotoxicity.	Frontiers in Immunology	2017
29023371	Expression Profiles of Ligands for Activating Natural Killer Cell Receptors on HIV Infected and Uninfected CD4âº T Cells.	Viruses	2017
27499379	Antibody-Dependent Cellular Cytotoxicity Activity of Effector Cells from HIV-Infected Elite and Viral Controllers.	AIDS Research and Human Retroviruses	2016
26978598	Proinflammatory isoforms of IL-32 as novel and robust biomarkers for control failure in HIV-infected slow progressors.	Scientific Reports	2016
27486665	Temporal Dynamics of CD8+ T Cell Effector Responses during Primary HIV Infection.	PLoS Pathog	2016
27849172	Novel E2 Glycoprotein Tetramer Detects Hepatitis C Virus-Specific Memory B Cells.	Journal of Immunology	2016
27506421	The differential impact of natural killer (NK) cell education via KIR2DL3 and KIR3DL1 on CCL4 secretion in the context of in-vitro HIV infection.	Clinical and Experimental Immunology	2016
27732638	NK Cells Expressing the Inhibitory Killer Immunoglobulin-Like Receptors (iKIR) KIR2DL1, KIR2DL3 and KIR3DL1 Are Less Likely to Be CD16+ than Their iKIR Negative Counterparts.	PLoS ONE	2016
26244383	Natural killer cell education does not affect the magnitude of granzyme B delivery to target cells by antibody-dependent cellular cytotoxicity.	AIDS	2015
25715101	The HLA-C*04: 01/KIR2DS4 gene combination and human leukocyte antigen alleles with high population frequency drive rate of HIV disease progression.	AIDS	2015
25713086	Functional analysis of NK cell subsets activated by 721.221 and K562 HLA-null cells.	Journal of Leukocyte Biology	2015
25339767	The HIV-1 gp120 CD4-bound conformation is preferentially targeted by antibody-dependent cellular cytotoxicity-mediating antibodies in sera from HIV-1-infected individuals.	Journal of Virology	2015
25924895	Impaired Th17 polarization of phenotypically naive CD4(+) T-cells during chronic HIV-1 infection and potential restoration with early ART.	Retrovirology	2015
25644502	Phenotypical and functional profiles of natural killer cells exhibiting matrix metalloproteinase-mediated CD16 cleavage after anti-HIV antibody-dependent activation.	Clinical and Experimental Immunology	2015
26202228	A Higher Frequency of NKG2A+ than of NKG2A- NK Cells Responds to Autologous HIV-Infected CD4 Cells irrespective of Whether or Not They Coexpress KIR3DL1.	Journal of Virology	2015
25125129	Flow cytometry-based assay to study HIV-1 gp120 specific antibody-dependent cellular cytotoxicity responses.	Journal of Virological Methods	2014
25330014	Time to seroconversion in HIV-exposed subjects carrying protective versus non protective KIR3DS1/L1 and HLA-B genotypes.	PLoS ONE	2014
24453969	HIV protective KIR3DL1/S1-HLA-B genotypes influence NK cell-mediated inhibition of HIV replication in autologous CD4 targets.	PLoS Pathogens	2014
25229650	eEF2 and Ras-GAP SH3 domain-binding protein (G3BP1) modulate stress granule assembly during HIV-1 infection.	Nature Communications	2014
23571168	On the benefits of sin: can greater understanding of the 1F7-idiotypic repertoire freeze enhance HIV vaccine development?	Human Vaccines and Immunotherapeutics	2013